help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van de Casteele, M.
Right arrow Articles by Pipeleers, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van de Casteele, M.
Right arrow Articles by Pipeleers, D. G.
Endocrinology Vol. 143, No. 1 320-326
Copyright © 2002 by The Endocrine Society


INSULIN-GLUCAGON-GI PEPTIDES-DIABETES MELLITUS

Specific Expression of Bax-{omega} in Pancreatic ß-Cells Is Down-Regulated by Cytokines before the Onset of Apoptosis

Mark Van de Casteele, Benjamin Ate Kefas, Zhidong Ling, Harry Heimberg and Daniel G. Pipeleers

Diabetes Research Center, Vrije Universiteit Brussel, B-1090 Brussels, Belgium

Address all correspondence and requests for reprints to: Dr. Mark Van de Casteele, Diabetes Research Center, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. E-mail: mvdcaste{at}vub.ac.be

Cytokines have been implicated in the process of pancreatic ß-cell destruction that leads to type 1 diabetes. This study investigates the ß-cell expression of pro- and antiapoptotic proteins from the Bcl-2 family and their variation during cytokine-mediated apoptosis. Exposure of rat ß-cells to the combination of IL-1ß plus interferon-{gamma} causes a time-dependent increase in apoptotic cells starting after 3 d (<10% on d 3 and 28 ± 2% on d 7). This effect was preceded by a marked down-regulation of two antiapoptotic proteins, Bcl-2 and Bax-{omega} (respectively reduced by 60% and 80% after 3 d), whereas no changes occurred in the expression of Bcl-xL and the proapoptotic protein Bax-{alpha}. No apoptosis or down-regulation of Bcl-2 and Bax-{omega} proteins was observed with individual cytokines or in the presence of N-methyl-L-arginine, an inhibitor of nitric oxide synthase. The lowered Bcl-2 protein content was associated with a decrease in Bcl-2 mRNA, which was initiated after 24 h of exposure. In MIN6 cells, the cytokine-induced suppression of Bcl-2- and Bax-{omega}, and apoptosis, occurred within 24 h. Primary rat ß-cells exhibited a higher expression of Bax-{omega} than MIN6 cells or than other rat cell types. These data suggest that suppression of the antiapoptotic proteins Bcl-2 and Bax-{omega} mediates cytokine-induced apoptosis of ß-cells. The ß-cell-specific expression of Bax-{omega} makes this protein a possible effector in the protection of this cell type against apoptosis.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. A. Martens, Y. Cai, S. Hinke, G. Stange, M. Van de Casteele, and D. Pipeleers
Glucose Suppresses Superoxide Generation in Metabolically Responsive Pancreatic {beta} Cells
J. Biol. Chem., May 27, 2005; 280(21): 20389 - 20396.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Z. Ling, M. Van de Casteele, J. Dong, H. Heimberg, J.-A. Haefliger, G. Waeber, F. Schuit, and D. Pipeleers
Variations in IB1/JIP1 Expression Regulate Susceptibility of {beta}-Cells to Cytokine-Induced Apoptosis Irrespective of C-Jun NH2-Terminal Kinase Signaling
Diabetes, October 1, 2003; 52(10): 2497 - 2502.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Jambal, S. Masterson, A. Nesterova, R. Bouchard, B. Bergman, J. C. Hutton, L. M. Boxer, J. E.-B. Reusch, and S. Pugazhenthi
Cytokine-mediated Down-regulation of the Transcription Factor cAMP-response Element-binding Protein in Pancreatic {beta}-Cells
J. Biol. Chem., June 13, 2003; 278(25): 23055 - 23065.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society